Washington, Sept 30 : Researchers have discovered that uveitis, an inflammatory eye disease may be treated with a compound that blocks the action of aldose reductase, an enzyme essential to the production of inflammatory signaling molecules.
Uveitis, the inflammation of the uvea, a layer of tissue that lies just below the outer surface of the eyeball and includes the iris, is a condition that can be caused by both autoimmune and infectious diseases.